Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1950 of 3546 entries
View as:

Food and Relative Bioavailability Study

Phase: N/A Priority: Normal
NCT ID: NCT00843011 Org: User:
Start: 08/28/08 End: 10/23/08 Due: 10/23/09

A Clinical Study to Investigate the Effects of Creatine Supplementation on Muscle Energetics and Cognitive Function in Young Healthy Male Athletes and an Ageing Population

Phase: N/A Priority: Normal
NCT ID: NCT02058654 Org: User:
Start: 12/01/13 End: 06/24/14 Due: 06/24/15

Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UK

Phase: N/A Priority: Normal
NCT ID: NCT01905462 Org: User:
Start: 11/30/12 End: 08/31/13 Due: 08/31/14

An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01231568 Org: User:
Start: 10/21/10 End: 05/13/11 Due: 05/13/12

Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01453296 Org: User:
Start: 08/31/10 End: 04/30/11 Due: 04/30/12

Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing Exacerbations

Phase: N/A Priority: Normal
NCT ID: NCT01381406 Org: User:
Start: 07/31/08 End: 09/30/10 Due: 09/30/11

Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)

Phase: N/A Priority: Normal
NCT ID: NCT00387972 Org: User:
Start: 05/31/06 End: 10/31/07 Due: 10/31/08

Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

Phase: N/A Priority: Normal
NCT ID: NCT00529516 Org: User:
Start: 10/15/07 End: 06/04/08 Due: 06/04/09

A Drug Interaction Study of Albiglutide and Digoxin

Phase: N/A Priority: Normal
NCT ID: NCT01147718 Org: User:
Start: 06/11/10 End: 11/29/10 Due: 11/29/11

Study to Evaluate an Influenza Vaccine Candidate

Phase: N/A Priority: Normal
NCT ID: NCT00321373 Org: User:
Start: 05/11/06 End: 07/18/06 Due: 07/18/07

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Phase: N/A Priority: Normal
NCT ID: NCT01498679 Org: User:
Start: 01/31/12 End: 07/31/13 Due: 07/31/14

A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.

Phase: N/A Priority: Normal
NCT ID: NCT00158860 Org: User:
Start: 06/21/04 End: 07/26/06 Due: 07/26/07

Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)

Phase: N/A Priority: Normal
NCT ID: NCT00480649 Org: User:
Start: 01/31/04 End: 09/30/05 Due: 09/30/06

Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT02212457 Org: User:
Start: 08/21/14 End: 03/03/16 Due: 03/03/17

Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)

Phase: N/A Priority: Normal
NCT ID: NCT02658435 Org: User:
Start: 02/02/16 End: 09/14/17 Due: 09/14/18

Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England

Phase: N/A Priority: Normal
NCT ID: NCT03278067 Org: User:
Start: 09/12/17 End: 11/30/17 Due: 11/30/18

A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00259935 Org: User:
Start: 10/04/04 End: 07/05/07 Due: 07/05/08

Study Of Ispinesib In Subjects With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00089973 Org: User:
Start: 06/30/04 End: 08/25/06 Due: 08/25/07

Chronic Obstructive Pulmonary Disease Endpoints Study

Phase: N/A Priority: Normal
NCT ID: NCT00358358 Org: User:
Start: 03/31/06 End: 02/28/07 Due: 02/28/08

Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK 134612

Phase: N/A Priority: Normal
NCT ID: NCT00974363 Org: User:
Start: 09/30/09 End: 05/31/13 Due: 05/31/14

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05966090 Org: User:
Start: 07/28/23 End: 07/29/24 Due: 07/29/25

Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children

Phase: N/A Priority: Normal
NCT ID: NCT00764790 Org: User:
Start: 10/01/08 End: 06/01/09 Due: 06/01/10

Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02786927 Org: User:
Start: 06/21/16 End: 10/04/16 Due: 10/04/17

Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00384306 Org: User:
Start: 06/30/04 End: 01/31/06 Due: 01/31/07

Bioequivalence - Duodart Against Avodart & Omnic

Phase: N/A Priority: Normal
NCT ID: NCT01657851 Org: User:
Start: 08/23/12 End: 12/05/12 Due: 12/05/13